After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
SMMT belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Summit Therapeutics Inc is $13.10B. A total of 1.78 million shares were traded on the day, compared to an average of 3.98M shares.
In the most recent transaction, Xia Yu bought 533,617 shares of SMMT for 18.74 per share on Oct 21 ’25. After the transaction, the Director now owns 32,057,147 company shares. In a previous transaction on Oct 21 ’25, DUGGAN ROBERT W bought 26,680 shares at 18.74 per share. SMMT shares that Co-Chief Executive Officer owns now total 76,680.
Among the insiders who bought shares, Zanganeh Mahkam acquired of 26,680 shares on Oct 21 ’25 at a per-share price of $18.74. This resulted in the Co-Chief Executive Officer holding 76,680 shares of SMMT after the transaction. In another insider transaction, Zanganeh Mahkam bought 333,394 shares at $17.68 per share on Sep 10 ’25. Company shares held by the Co-Chief Executive Officer now total 556,088,090.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, SMMT has a high of $36.91 and a low of $15.55.
As of this writing, SMMT has an earnings estimate of -$0.02 per share for the current quarter. EPS was calculated based on a consensus of 11.0 estimates, with a high estimate of $0.76 per share and a lower estimate of -$0.24. The company reported an EPS of -$0.06 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. SMMT’s latest balance sheet shows that the firm has $71.79M in Cash & Short Term Investments as of fiscal 2021. There were $2.78M in debt and $25.62M in liabilities at the time. Its Book Value Per Share was $0.26, while its Total Shareholder’s Equity was $83.28M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SMMT is Buy with a score of 4.18.
